Machine Learning

A new partnership combines AI design with rapid lab testing to crack the code of complex proteins, speeding up drug discovery and opening new frontiers.

Forget simple indicators. A new breed of retail trader uses complex data, automation, and strict risk rules to gain a professional edge in the market.

Oculis appoints former Cooley partner Katie Kazem as CLO, a strategic move to fortify governance ahead of pivotal data readouts for its late-stage eye drugs.

IDC MarketScape recognizes Hitachi Energy's leadership in asset management as utilities race to balance aging grids with a clean energy future.

A new study uses PET-CT scans to track CIT-013, a first-in-class antibody targeting the root cause of inflammation in rheumatoid arthritis and HS.

A Swedish biotech and Belgian university secure major EU funding to advance a first-in-class drug against glioblastoma, a notoriously deadly brain tumor.

A record-breaking drone and air taxi display at the Spring Festival Gala was more than a show; it was a bold statement on China's low-altitude economy.

With a novel glutamate-targeting drug and a €38M cash injection, Newron aims to transform care for treatment-resistant schizophrenia.

Amidst global supply chain chaos, SEKO Logistics posts a +71 NPS, far surpassing industry averages. Here’s how they turned service into a science.

Indian fintech IBSFINtech is reshaping corporate finance with its AI platform, earning a top spot in a key IDC report. Here’s how it’s done.

A new fitness app by Dr. Jim Stoppani offers military-specific training, challenging the subscription model with a science-first, one-time purchase plan.

A new genomics tracker reveals the fragmented adoption of precision cancer care across the EU-5, highlighting critical barriers and strategic opportunities.

Direct-to-Film printing is maturing, driven by automation, powderless systems, and advanced color, moving from niche to industrial-scale production.

A new AI search platform promises to decode complex zoning and accelerate land deals, transforming a multi-trillion dollar industry long slowed by manual work.

A new report reveals a crisis in fraud prevention, as sophisticated AI-driven scams outpace corporate defenses and put customer experience at risk.

With its expansion to Europe and LATAM, Halper AI and its founder are betting on a radical idea: the best AI is the one you never have to open.

Zemcelpro® gains key reimbursement status, offering immediate hope and access for German patients with limited options and paving a new path for cell therapy.

AI biotech firm Juvenescence hires a top CTO and moves into Abu Dhabi, aiming to unlock anti-aging secrets with massive genomic data and AI.

A landmark trial shows Retevmo significantly cuts cancer recurrence in early-stage patients, pushing for a new standard of care and early genetic testing.

Dr. Batra's launches XODerma, a high-tech exosome skin therapy in Dubai, blending homeopathy with cellular science. But does the hype outpace regulation?